Article Details
Retrieved on: 2021-07-29 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ocrelizumab, a humanized monoclonal antibody that selectively targets CD20+ B-cells, profoundly suppresses acute inflammatory disease activity, ...
Article found on: www.dovepress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here